Regulation of DARPP-32 Thr75 phosphorylation by neurotensin in neostriatal neurons: Involvement of glutamate signalling

European Journal of Neuroscience

Volumn 18, Issue 5, 2003, Pages 1247-1253

  Matsuyama, Seiichiro ^a   Fukui, Ryuichi ^a   Higashi, Hideho ^a   Nishi, Akinori ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AMPA; Cdk5; Dopamine; Mouse; NMDA

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; 2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIZOCILPINE; GLUTAMIC ACID; LEVOCABASTINE; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR ANTAGONIST; PHOSPHOPROTEIN DARPP 32; PROTEIN KINASE INHIBITOR; RACLOPRIDE; TETRODOTOXIN; THREONINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG EFFECT; DRUG MECHANISM; INCUBATION TIME; MALE; MOUSE; NEOSTRIATUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANESTHETICS, LOCAL; ANIMALS; DIZOCILPINE MALEATE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HISTAMINE H1 ANTAGONISTS; IMMUNOBLOTTING; MALE; MICE; MICE, INBRED C57BL; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEURONS; NEUROTENSIN; PHOSPHOPROTEINS; PIPERIDINES; PYRAZOLES; QUINOLINES; RACLOPRIDE; RECEPTORS, NEUROTENSIN; SIGNAL TRANSDUCTION; TETRODOTOXIN; THREONINE; TIME FACTORS;

EID: 0141836842     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02859.x     Document Type: Article

References (40)

1. Betancur, C., Azzi, M. & Rostene, W. (1997) Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. Trends Pharmacol. Sci., 18, 372-386.
2. 3H]SR 48692, in the guinea pig brain. J. Pharmacol. Exp. Ther., 273, 1450-1458.
3. Bibb, J.A., Snyder, G.L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A.A., Tsai, L.H., Kwon, Y.T., Girault, J.A., Czernik, A.J., Huganir, R.L., Hemmings, H.C., Jr, Nairn, A.C. & Greengard, P. (1999) Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature, 402, 669-671.
4. Binder, E.B., Kinkead, B., Owen, M.J. & Nemeroff, C.B. (2001) Neurotensin and dopamine interactions. Pharmacol. Rev., 53, 453-486.
5. Boudin, H., Pelaprat, D., Rostene, W. & Beaudet, A. (1996) Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J. Comp. Neurol., 373, 76-89.
6. Cepeda, C., Hurst, R.S., Calvert, C.R., Hernandez-Echeagaray, E., Nguyen, O.K., Jocoy, E., Christian, L.J., Ariano, M.A. & Levine, M.S. (2003) Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J. Neurosci., 23, 961-969.
7. Dal Farra, C., Sarret, P., Navarro, V., Botto, J.M., Mazella, J. & Vincent, J.P. (2001) Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines. Int. J. Cancer, 92, 503-509.
8. Ferraro, L., O'Connor, W.T., Antonelli, T., Fuxe, K. & Tanganelli, S. (1997) Differential effects of intrastriatal neurotensin (1-13) and neurotensin (8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat. Eur. J. Neurosci., 9, 1838-1846.
9. Ferraro, L., Tanganelli, S., O'Connor, W.T., Bianchi, C., Ungerstedt, U. & Fuxe, K. (1995) Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat. Synapse, 20, 362-364.
10. Fienberg, A.A. & Greengard, P. (2000) The DARPP-32 knockout mouse. Brain Res. Rev., 31, 313-319.
11. Fienberg, A.A., Hiroi, N., Mermelstein, P., Song, W.-J., Snyder, G.L., Nishi, A., Cheramy, A., O'Callaghan, J.P., Miller, D., Cole, D., Corbett, R., Haile, C., Cooper, D., Onn, S., Grace, A.A., Ouimet, C., White, F.J., Hyman, S.E., Surmeier, D.J., Girault, J.A., Nestler, E. & Greengard, P. (1998) DARPP-32, regulator of the efficacy of dopaminergic neurotransmission. Science, 281, 838-842.
12. Greengard, P., Allen, P.B. & Nairn, A.C. (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron, 23, 435-447.
13. Gully, D., Canton, M., Boigegrain, R., Jeanjean, F., Molimard, J.C., Poncelet, M., Gueudet, C., Heaulme, M., Leyris, R., Brouard, A. et al. (1993) Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. Natl Acad. Sci. USA, 90, 65-69.
14. 3H]dopamine release evoked by KCl versus electrical depolarization. Neuropharmacology, 36, 1447-1454.
15. Hemmings, H.C. Jr & Greengard, P. (1986) DARPP-32, a dopamine- and adenosine 3′: 5′-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution. J. Neurosci., 6, 1469-1481.
16. Hemmings, H.C., Jr, Greengard, P., Tung, H.Y.L. & Cohen, P. (1984) DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature, 310, 503-505.
17. Kinkead, B., Binder, E.B. & Nemeroff, C.B. (1999) Does neurotensin mediate the effects of antipsychotic drugs? Biol. Psychiatry, 46, 340-351.
18. Kitabgi, P. (1989) Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways. Neurochem. Int., 14, 111-119.
19. Lindskog, M., Svenningsson, P., Pozzi, L., Kim, Y., Fienberg, A.A., Bibb, J.A., Fredholm, B.B., Nairn, A.C., Greengard, P. & Fisone, G. (2002) Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature, 418, 774-778.
20. Liu, F., Ma, X.-H., Ule, J., Bibb, J.A., Nishi, A., DeMaggio, A.J., Yan, Z., Nairn, A.C. & Greengard, P. (2001) Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc. Natl Acad. Sci. USA, 98, 11062-11068.
21. Martin, S., Navarro, V., Vincent, J.P. & Mazella, J. (2002) Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology, 123, 1135-1143.
22. Martin, S., Vincent, J.P. & Mazella, J. (2003) Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J. Neurosci., 23, 1198-1205.
23. Matsuyama, S., Higashi, H., Maeda, H., Greengard, P. & Nishi, A. (2002) Neurotensin regulates DARPP-32 Thr34 phosphorylation in neostriatal neurons by stimulating the release of dopamine. J. Neurochem., 81, 325-334.
24. Mazella, J. (2001) Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking? Cell Signal, 13, 1-6.
25. Nemeroff, C.B. (1980) Neurotensin: perchance an endogenous neuroleptic? Biol. Psychiatry, 15, 283-302.
26. Nishi, A., Bibb, J.A., Matsuyama, S., Hamada, M., Higashi, H., Nairn, A.C. & Greengard, P. (2002) Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A. J. Neurochem., 81, 832-841.
27. Nishi, A., Bibb, J.A., Snyder, G.L., Higashi, H., Nairn, A.C. & Greengard, P. (2000) Amplification of dopaminergic signaling by a positive feedback loop. Proc. Natl Acad. Sci. USA, 97, 12840-12845.
28. 2A receptor signaling. Proc. Natl Acad. Sci. USA, 100, 1322-1327.
29. Nishi, A., Snyder, G.L., Nairn, A.C. & Greengard, P. (1999) Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. J. Neurochem., 72, 2015-2021.
30. O'Connor, W.T., Tanganelli, S., Ungerstedt, U. & Fuxe, K. (1992) The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: an in vivo microdialysis study. Brain Res., 573, 209-216.
31. Okuma, Y., Fukuda, Y. & Osumi, Y. (1983) Neurotensin potentiates the potassium-induced release of endogenous dopamine from rat striatal slices. Eur. J. Pharmacol., 93, 27-33.
32. Ouimet, C.C., Miller, P.E., Hemmings, H.C., Jr, Walaas, S.I. & Greengard, P. (1984) DARPP-32, a dopamine- and adenosine 3′: 5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci., 4, 114-124.
33. Sarret, P., Krzywkowski, P., Segal, L., Nielsen, M.S., Petersen, C.M., Mazella, J., Stroh, T. & Beaudet, A. (2003) Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system. J. Comp. Neurol., 461, 483-505.
34. Schotte, A., Rostene, W. & Laduron, P.M. (1988) Different subcellular localization of neurotensin-receptor and neurotensin-acceptor sites in the rat brain dopaminergic system. J. Neurochem., 50, 1026-1031.
35. Svenningsson, P., Tzavara, E.T., Liu, F., Fienberg, A.A., Nomikos, G.G. & Greengard, P. (2002) DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc. Natl Acad. Sci. USA, 99, 3188-3193.
36. Towbin, H., Staehlin, T. & Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocullulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
37. Trudeau, L.E. (2000) Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes: evidence for the involvement of multiple receptors. Neuroscience, 97, 293-302.
38. Tyler-McMahon, B.M., Boules, M. & Richelson, E. (2000) Neurotensin: peptide for the next millennium. Regul. Pept., 93, 125-136.
39. Vincent, J.P., Mazella, J. & Kitabgi, P. (1999) Neurotensin and neurotensin receptors. Trends Pharmacol. Sci., 20, 302-309.
40. Walaas, S.I. & Greengard, P. (1984) DARPP-32, a dopamine- and adenosine 3′: 5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in rat brain. J. Neurosci., 4, 84-98.